ISRL Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
0
0
0
0
0
Cost of Revenue
0
0
0
0
0
Gross Profit
0
0
0
0
0
Operating Expenses
126.6K
-48.4%
245.3K
-3.0%
252.9K
-10.0%
281.0K
-19.5%
349.1K
R&D
0
0
0
0
0
SG&A
30.9K
+5.1%
29.4K
-49.0%
57.6K
-10.0%
64.0K
+6.5%
60.1K
Operating Income
-126556
+48.4%
-245323
+3.0%
-252879
+10.0%
-280990
+19.5%
-349125
EBITDA
-45450
+35.5%
-70502
+35.7%
-109729
+20.7%
-138410
+14.7%
-162244
Net Income
-65062
+62.4%
-172916
-9.2%
-158330
+12.2%
-180427
+24.2%
-238126
EPS (Basic)
$-0.02
+50.0%
$-0.04
—
$-0.06
+14.3%
$-0.07
EPS (Diluted)
$-0.02
+50.0%
$-0.04
—
$-0.06
+14.3%
$-0.07
Shares (Diluted)
3.5M
+362.6%
762.5K
—
762.5K
-76.4%
3.2M
Defiance KSM Israel 120 ETF (ISRL) — Financials